Printer Friendly

THE UPJOHN COMPANY SELECTS CHAIRMAN AND CHIEF EXECUTIVE OFFICER

 KALAMAZOO, Mich., Dec. 7 /PRNewswire/ -- The Upjohn Company (NYSE: UPJ) today announced that its Board of Directors has elected John L. Zabriskie, Ph.D., Chairman of the Board and Chief Executive Officer of the company. He was also elected to Upjohn's Board of Directors. Zabriskie will officially begin his duties at Upjohn on January 3, 1994.
 Zabriskie, 54, is currently Executive Vice President of Merck and Company and President of Merck's Manufacturing Division. He has spent his entire career with Merck after joining the company in 1965. Most recently, he headed up the transition team coordinating integration of Merck's $6 billion acquisition of Medco Pharmaceuticals while maintaining responsibility for Merck's worldwide manufacturing operations.
 "The Upjohn Board of Directors believes that Dr. Zabriskie is the right person for Upjohn," said William E. LaMothe, Chairman of the Upjohn Board Special Search Committee and former Chairman and Chief Executive Officer of Kellogg Company. "His comprehensive knowledge of all aspects of the pharmaceutical industry and his outstanding track record at Merck make him uniquely qualified for the job."
 Upjohn has been without a CEO since the death of Theodore Cooper, M.D., Ph.D., in April 1993. Since that time Ley S. Smith, President and Chief Operating Officer, has served as acting CEO.
 "The Board of Directors wishes to thank Ley Smith and the Upjohn management team for their efforts during the interim period," LaMothe said. "They have taken several important steps, including a major realignment of operations announced in October, that will help Upjohn be more competitive in the future."
 Zabriskie graduated from Dartmouth College with honors in chemistry and obtained a Ph.D. in organic chemistry from the University of Rochester before joining Merck as a chemist in 1965. Initially, he was responsible for the development of new chemical syntheses and the planning and coordination of safety and efficacy tests for new animal health products. In 1970, he was appointed senior manager of Pharmaceutical Quality Control at Merck, Sharp & Dohme (MSD) in West Point, Pa., and became director of Pharmaceutical Manufacturing there in 1974. He relocated to Merck corporate headquarters in 1979 when he was appointed secretary to the company's New Products Committee.
 In 1980, Zabriskie returned to West Point where he became Director of Marketing Planning with responsibility for developing marketing programs for the company's ophthalmic, psychotherapeutic and anti- infective products. In 1982 he was appointed Director of Management Engineering, and in 1983 he was named President of Merck Frosst Canada, Inc., where he led the successful industry effort to restore patent protection for pharmaceutical products in Montreal. He returned to West Point in 1988 as President of MSD, in charge of Merck's pharmaceutical sales and marketing in the United States, and began the company's successful entry into the managed care markets.
 He was elected Senior Vice President of Merck in 1991 and assumed the additional title and responsibilities of President, Merck Manufacturing Division, later that year. Zabriskie was elected Executive Vice President of Merck & Co., Inc., and President, Merck Manufacturing Division, in January 1993, with additional responsibilities for Worldwide Public Affairs and Merck's Kelco Division, a leading manufacturer of specialty chemicals.
 He is active in industry affairs, most recently in the debate over health care reform as a member of the Jackson Hole Group and the Healthcare Leadership Council. Zabriskie is also active in civic affairs and currently serves as a trustee of Morristown Memorial Hospital and as a member of the Board of Morristown Memorial Physician Hospital Organization.
 "Upjohn is facing a number of near-term challenges, including the expiration of patents for several important products," Zabriskie said. "At the same time, the company has a number of promising products in its pipeline and significant opportunities for growth. I am very enthusiastic about joining such a great company with its long and rich heritage and its wonderful reputation," he added.
 Zabriskie is married to Dr. Adelaide Zabriskie. They have four grown children and currently reside in Bernardsville, N.J. He and his wife will move to the Kalamazoo area.
 The Upjohn Company is a worldwide, research-based provider of human health care products, animal health products, agronomic and vegetable seeds and
specialty chemicals. Headquartered in Kalamazoo, the company has been dedicated to improving health and nutrition for more than a century.
 -0- 12/7/93
 /NOTE TO EDITORS: A photo of Upjohn's new chairman will be transmitted on AP PhotoExpress Dec. 7. See photo PRN1. In addition, the photo is available at no charge to any media with a telephoto receiver or electronic darkroom (PC or Macintosh) that can accept overhead transmissions. To retrieve the photo, please call 214-416-3686./
 /CONTACT: John P. Lambrechts, 616-323-7076, or Barbara L. Guinness (investors), 616-323-5918, both of Upjohn/
 (UPJ)


CO: The Upjohn Company ST: Michigan IN: MTC SU: PER

ML-SB -- DE009 -- 1316 12/07/93 13:16 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 7, 1993
Words:802
Previous Article:DISCOVERY ZONE FUNCENTERS TO OFFER DZ KiDZ WATCH PROGRAM FOR HOLIDAY SHOPPERS; PROGRAM TO PROVIDE CHILD CARE WHILE PARENTS SHOP
Next Article:CMS/DATA CORPORATION'S PRINCIPLE SHAREHOLDER EXECUTES DEFINITIVE AGREEMENT
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters